<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03960203</url>
  </required_header>
  <id_info>
    <org_study_id>05172019</org_study_id>
    <nct_id>NCT03960203</nct_id>
  </id_info>
  <brief_title>Effect of a Sepsis Prediction Algorithm on Clinical Outcomes</brief_title>
  <official_title>Effect of a Sepsis Prediction Algorithm on Patient Mortality, Length of Stay, and Readmission</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dascena</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dascena</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this clinical outcomes analysis, the effect of a machine learning algorithm for severe
      sepsis prediction on in-hospital mortality, hospital length of stay, and 30-day readmission
      was evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Materials and Methods: Clinical outcomes evaluation performed on a multiyear, multicenter
      clinical data set of real-world data containing 75,147 patient encounters from nine
      hospitals. Mortality, hospital length of stay, and 30-day readmission analysis performed for
      17,758 adult patients who met two or more Systemic Inflammatory Response Syndrome (SIRS)
      criteria at any point during their stay.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Actual">June 2018</completion_date>
  <primary_completion_date type="Actual">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>1 year</time_frame>
    <description>Rate of in-hospital mortality based on SIRS criteria</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>1 year</time_frame>
    <description>Duration of hospital length of stay in days based on SIRS criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day readmissions</measure>
    <time_frame>1 year</time_frame>
    <description>Rate of patient readmissions within 30 days</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">75147</enrollment>
  <condition>Severe Sepsis</condition>
  <arm_group>
    <arm_group_label>Comparator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The comparator arm will involve patients monitored by InSight.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>InSight</intervention_name>
    <description>Clinical decision support (CDS) system for severe sepsis detection and prediction</description>
    <arm_group_label>Comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients over the age of 18 presenting to the emergency department or admitted to
             an inpatient unit at the participating facilities were automatically included for
             clinical outcomes analysis

        Exclusion Criteria:

          -  Patients under the age of 18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ritankar Das, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dascena</affiliation>
  </overall_official>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 17, 2019</study_first_submitted>
  <study_first_submitted_qc>May 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2019</study_first_posted>
  <last_update_submitted>May 22, 2019</last_update_submitted>
  <last_update_submitted_qc>May 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dascena</keyword>
  <keyword>Patient mortality</keyword>
  <keyword>Length of stay</keyword>
  <keyword>Readmissions</keyword>
  <keyword>Algorithm</keyword>
  <keyword>Diagnostic</keyword>
  <keyword>Clinical outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

